Dachaigh › Fibrolamellar hepatocellular carcinoma
Sgrùdaidhean clionaigeach Fibrolamellar hepatocellular carcinoma a’ fastadh anns na SA
Tha 5 sgrùdaidhean airson Fibrolamellar hepatocellular carcinoma a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
Le stàit
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
A’ fastadhÌre 1
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07430202Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
A’ fastadhÌre 1/2
Suas gu aois 30 · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT05468359Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
A’ fastadhÌre 2
Aoisean 0 gu 30 · Gach gnè · Air ùrachadh 24 Gearr 2026 · NCT04134559DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 12 Gearr 2026 · NCT06027086DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
A’ fastadhÌre 1
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 3 Dùbh 2025 · NCT04248569Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.